Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to determine whether fasting and post-prandial glucagon secretion is suppressed by gliclazide in patients with HNF1-/4-alpha MODY. Participants will undergo an oral glucose tolerance test (OGTT) before and after omitting their gliclazide medication for 3 days.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03246828
Study type Interventional
Source University of Oxford
Contact
Status Completed
Phase N/A
Start date July 3, 2017
Completion date August 1, 2022